These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 12091858

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. What influences early hypothyroidism after radioiodine treatment for Graves' hyperthyroidism?
    Vijayakumar V, Ali S, Nishino T, Nusynowitz M.
    Clin Nucl Med; 2006 Nov; 31(11):688-9. PubMed ID: 17053385
    [Abstract] [Full Text] [Related]

  • 4. A simplified method for treating Graves' disease with radioactive 131I.
    Masri MT, Menne M, Rooney BL, Caplan RH.
    Wis Med J; 1995 Jan; 94(1):21-5. PubMed ID: 7871797
    [Abstract] [Full Text] [Related]

  • 5. Early treatment with low fixed dose (5 mCi) radioiodine therapy is effective in Indian subjects with Graves' disease.
    Sanyal D, Mukhhopadhyay P, Pandit K, Chatterjee J, Raychaudhuri M, Mukherjee S, Chowdhury S.
    J Indian Med Assoc; 2008 Jun; 106(6):360-1, 372. PubMed ID: 18839646
    [Abstract] [Full Text] [Related]

  • 6. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH, Pusuwan P, Likitmaskul S, Santiprabhob J, Sawathiparnich P.
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC, Zanin DE, Zweers EJ.
    Ned Tijdschr Geneeskd; 2002 Sep 28; 146(39):1837-41. PubMed ID: 12382370
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study.
    Howarth D, Epstein M, Lan L, Tan P, Booker J.
    Eur J Nucl Med; 2001 Oct 28; 28(10):1489-95. PubMed ID: 11685491
    [Abstract] [Full Text] [Related]

  • 10. Radioiodine treatment outcomes in thyroid glands previously irradiated for Graves' hyperthyroidism.
    Leslie WD, Peterdy AE, Dupont JO.
    J Nucl Med; 1998 Apr 28; 39(4):712-6. PubMed ID: 9544686
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
    Alfadda A, Malabu UH, El-Desouki MI, Al-Rubeaan KA, Al-Ruhaily AD, Fouda MA, Al-Maatouq MA, Sulimani RA.
    Saudi Med J; 2007 Feb 28; 28(2):225-30. PubMed ID: 17268701
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Radioiodine-induced hypothyroidism in Graves' disease: factors associated.
    Cunnien AJ, Hay ID, Gorman CA, Offord KP, Scanlon PW.
    J Nucl Med; 1982 Nov 28; 23(11):978-83. PubMed ID: 6897075
    [Abstract] [Full Text] [Related]

  • 16. Radioactive iodine therapy for pediatric Graves' disease: a single-center experience over a 10-year period.
    Kaplowitz PB, Jiang J, Vaidyanathan P.
    J Pediatr Endocrinol Metab; 2020 Mar 26; 33(3):383-389. PubMed ID: 31603857
    [Abstract] [Full Text] [Related]

  • 17. [Results of treatment of Graves-Basedow disease with 131I at low calculated doses].
    Gómez Arnaiz N, Gómez Saez JM, Orti Llavería A, Gavaldá Mestre L, Mairal Pairó L, Soler Ramón J.
    Rev Clin Esp; 1998 Feb 26; 198(2):57-60. PubMed ID: 9558917
    [Abstract] [Full Text] [Related]

  • 18. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
    Walter MA, Christ-Crain M, Eckard B, Schindler C, Nitzsche EU, Müller-Brand J, Müller B.
    Eur J Clin Invest; 2004 May 26; 34(5):365-70. PubMed ID: 15147334
    [Abstract] [Full Text] [Related]

  • 19. Evidence for higher success rates and successful treatment earlier in Graves' disease with higher radioactive iodine doses.
    Sztal-Mazer S, Nakatani VY, Bortolini LG, Boguszewski CL, Graf H, de Carvalho GA.
    Thyroid; 2012 Oct 26; 22(10):991-5. PubMed ID: 22953990
    [Abstract] [Full Text] [Related]

  • 20. Transient hypothyroidism after iodine-131 therapy for Grave's disease.
    Gómez N, Gómez JM, Orti A, Gavaldà L, Villabona C, Leyes P, Soler J.
    J Nucl Med; 1995 Sep 26; 36(9):1539-42. PubMed ID: 7658207
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.